Target Name: ZFP28-DT
NCBI ID: G101928982
Other Name(s): ZFP28 divergent transcript, transcript variant X3 | ZFP28 divergent transcript | ZFP28-DT variant X3

ZFP28-DT: A Potential Drug Target or Biomarker for Various Diseases

ZFP28-DT, also known as ZFP28 divergent transcript or transcript variant X3, is a gene that has been identified as a potential drug target or biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

The ZFP28 gene is located on chromosome 16 and encodes for the zinc finger protein 28 (ZFP28), which is a transcription factor that plays a role in regulating gene expression and cell development. ZFP28 has been shown to be involved in a variety of cellular processes, including cell adhesion, migration, and survival.

Transcript variants of the ZFP28 gene have been identified, and some of these variants have been shown to have altered function. One of these variants, known as ZFP28-DT, has been shown to have altered gene expression and cell behavior.

ZFP28-DT has been shown to promote the expression of genes involved in cell adhesion, migration, and survival. It has also been shown to play a role in the development of cancer. For example, studies have shown that high levels of ZFP28-DT expression are associated with poor prognosis in breast cancer.

In addition to its potential role in cancer, ZFP28-DT has also been shown to be involved in neurodegenerative diseases. For example, studies have shown that ZFP28-DT is involved in the development of neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease.

ZFP28-DT has also been shown to be involved in autoimmune disorders. For example, studies have shown that ZFP28-DT is involved in the development of autoimmune disorders, including rheumatoid arthritis and multiple sclerosis.

Despite its potential role in a variety of diseases, ZFP28-DT has not yet been studied extensively, and more research is needed to fully understand its function and potential as a drug target or biomarker.

In conclusion, ZFP28-DT is a gene that has been identified as a potential drug target or biomarker for a variety of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Further research is needed to fully understand its function and potential as a drug.

Protein Name: ZFP28 Divergent Transcript

More Common Targets

ZFP3 | ZFP30 | ZFP36 | ZFP36L1 | ZFP36L2 | ZFP37 | ZFP41 | ZFP42 | ZFP57 | ZFP62 | ZFP64 | ZFP64P1 | ZFP69 | ZFP69B | ZFP82 | ZFP90 | ZFP91 | ZFP91-CNTF | ZFP92 | ZFPL1 | ZFPM1 | ZFPM2 | ZFPM2-AS1 | ZFR | ZFR2 | ZFTA | ZFTRAF1 | ZFX | ZFX-AS1 | ZFY | ZFYVE1 | ZFYVE16 | ZFYVE19 | ZFYVE21 | ZFYVE26 | ZFYVE27 | ZFYVE28 | ZFYVE9 | ZFYVE9P1 | ZG16 | ZG16B | ZGLP1 | ZGPAT | ZGRF1 | ZHX1 | ZHX1-C8orf76 | ZHX2 | ZHX3 | ZIC1 | ZIC2 | ZIC3 | ZIC4 | ZIC5 | ZIK1 | ZIM2 | ZIM3 | Zinc finger protein GLI | ZKSCAN1 | ZKSCAN2 | ZKSCAN3 | ZKSCAN4 | ZKSCAN5 | ZKSCAN7 | ZKSCAN8 | ZKSCAN8P1 | ZMAT1 | ZMAT2 | ZMAT3 | ZMAT4 | ZMAT5 | ZMIZ1 | ZMIZ1-AS1 | ZMIZ2 | ZMPSTE24 | ZMYM1 | ZMYM2 | ZMYM3 | ZMYM4 | ZMYM4-AS1 | ZMYM5 | ZMYM6 | ZMYND10 | ZMYND11 | ZMYND12 | ZMYND15 | ZMYND19 | ZMYND8 | ZNF10 | ZNF100 | ZNF101 | ZNF106 | ZNF107 | ZNF112 | ZNF114 | ZNF117 | ZNF12 | ZNF121 | ZNF124 | ZNF131 | ZNF132